These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 1673971)

  • 1. Assessment of beta-1 selectivity of bisoprolol and atenolol by means of their influence on the lipolytic response to an infusion of terbutaline.
    Kendall MJ; Akhlaghi S; Haffner CA
    J Clin Pharm Ther; 1991 Feb; 16(1):25-9. PubMed ID: 1673971
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A comparison of the beta1-selectivity of three beta1-selective beta-blockers.
    Nuttall SL; Routledge HC; Kendall MJ
    J Clin Pharm Ther; 2003 Jun; 28(3):179-86. PubMed ID: 12795776
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Beta 1-adrenoceptor selectivity of single oral doses of bisoprolol and atenolol.
    Chang PC; van Veen S; van der Krogt JA; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1988 Sep; 12(3):317-22. PubMed ID: 2464104
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A dose-ranging study to evaluate the beta 1-adrenoceptor selectivity of bisoprolol.
    Lipworth BJ; Irvine NA; McDevitt DG
    Eur J Clin Pharmacol; 1991; 40(2):135-9. PubMed ID: 1676675
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiac and vascular beta-adrenoceptor-mediated responses before and during treatment with bisoprolol or atenolol.
    Bolli P; Müller FB; Linder L; Ji BH; Bühler FR
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S61-4. PubMed ID: 2439800
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Investigation of the effects of beta-2 stimulation on free fatty acids in man.
    Kendall MJ; Clark NW; Haffner CA; Kong J; Hughes BA
    J Clin Pharm Ther; 1991 Feb; 16(1):31-40. PubMed ID: 2026667
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacodynamic profile of bisoprolol, a new beta 1-selective adrenoceptor antagonist.
    Leopold G; Ungethüm W; Pabst J; Simane Z; Bühring KU; Wiemann H
    Br J Clin Pharmacol; 1986 Sep; 22(3):293-300. PubMed ID: 2876722
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Double-blind comparison of the beta 1-selectivity of single doses of bisoprolol and atenolol.
    Chang PC; van Veen S; Vermeij P; van Brummelen P
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S58-60. PubMed ID: 2439799
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The lipolytic effect of beta 1- and beta 2-adrenoceptor activation in healthy human volunteers.
    Haffner CA; Kendall MJ; Maxwell S; Hughes B
    Br J Clin Pharmacol; 1993 Jan; 35(1):35-9. PubMed ID: 8383517
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A metabolic assessment of the beta 1 selectivity of bisoprolol.
    Haffner CA; Horton RC; Lewis HM; Hughes B; Kendall MJ
    J Hum Hypertens; 1992 Oct; 6(5):397-400. PubMed ID: 1361206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reduction of exercise tachycardia in man after propranolol, atenolol and bisoprolol in comparison to beta-adrenoceptor occupancy.
    Wellstein A; Palm D; Belz GG; Butzer R; Polsak R; Pett B
    Eur Heart J; 1987 Dec; 8 Suppl M():3-8. PubMed ID: 2897299
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The cardioselective and hypotensive effects of bisoprolol in hypertensive asthmatics.
    Chatterjee SS
    J Cardiovasc Pharmacol; 1986; 8 Suppl 11():S74-7. PubMed ID: 2439803
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effect of bisoprolol and atenolol on endurance exercise capacity in healthy men.
    Vanhees L; Defoor JG; Schepers D; Lijnen P; Peeters BY; Lacante PH; Fagard RH
    J Hypertens; 2000 Jan; 18(1):35-43. PubMed ID: 10678541
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Modification of dobutamine- and terbutaline-induced calcium and fluid secretion from rat salivary glands by atenolol and butoxamine.
    Schneyer CA; Yu JH; Jirakulsomchok D
    J Auton Nerv Syst; 1985 Aug; 13(4):275-85. PubMed ID: 2993403
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Beta-receptor selectivity of carvedilol and metoprolol succinate in patients with heart failure (SELECT trial): a randomized dose-ranging trial.
    Zebrack JS; Munger M; Macgregor J; Lombardi WL; Stoddard GP; Gilbert EM
    Pharmacotherapy; 2009 Aug; 29(8):883-90. PubMed ID: 19637941
    [TBL] [Abstract][Full Text] [Related]  

  • 16. S-Mg does not change inversely to S-FFA during acute stress situations.
    Hansen O; Johansson BW
    Angiology; 1989 Nov; 40(11):1011-9. PubMed ID: 2573295
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bisoprolol: a new beta-adrenoceptor blocking drug.
    Prichard BN
    Eur Heart J; 1987 Dec; 8 Suppl M():121-9. PubMed ID: 2897295
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V; Antonacci A; Prandi P; Bokor D; Pirrelli A
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effects of single oral doses of bisoprolol and atenolol on airway function in nonasthmatic chronic obstructive lung disease and angina pectoris.
    Dorow P; Bethge H; Tönnesmann U
    Eur J Clin Pharmacol; 1986; 31(2):143-7. PubMed ID: 2879733
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Beta 1-selectivity of bisoprolol, a new beta-adrenoceptor antagonist, in anesthetized dogs and guinea pigs.
    Schliep HJ; Harting J
    J Cardiovasc Pharmacol; 1984; 6(6):1156-60. PubMed ID: 6084774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.